The REMS Directory is a comprehensive listing of factual information about Risk Evaluation and Mitigation Strategy (REMS) programs with relevant information about the product for which the REMS was required. Products for which REMS have been required and approved by the FDA appear in the Approved REMS listing. Products approved before the provisions of the Food and Drug Administration Amendments Act (FDAAA) took effect that have been deemed to have a REMS appear in the Deemed REMS listing.
We have provided access to comprehensive information on a select number of products below (
). For additional information on other products listed, please contact us.
| Generic Name: tocilzumab | Status: Approved |
| NDA/BLA Holder: Hoffman LaRoche | NDA/BLA Number: BLA 125276/0 | NDA/BLA Approval: 1/8/2010 |
| Generic Name: pioglitazone hydrochloride and metformin hydrochloride | Status: Approved |
| NDA/BLA Holder: Takeda | NDA/BLA Number: NDA 21-842/S-009 | NDA/BLA Approval: 8/29/2005 |
| Generic Name: pioglitazone hydrochloride and metformin hydrochloride extended-release | Status: Approved |
| NDA/BLA Holder: Takeda | NDA/BLA Number: NDA 22-024 | NDA/BLA Approval: 5/12/2009 |
| Generic Name: pioglitazone hydrochloride | Status: Approved |
| NDA/BLA Holder: Takeda | NDA/BLA Number: NDA 21-073/S-037 | NDA/BLA Approval: 7/15/1999 |
| Generic Name: fluticasone propionate and salmeterol xinafoate | Status: Approved |
| NDA/BLA Holder: GlaxoSmithKline | NDA/BLA Number: NDA 21-077/S-029 | NDA/BLA Approval: 8/24/2000 |
| Generic Name: fluticasone propionate and salmeterol xinafoate | Status: Approved |
| NDA/BLA Holder: GlaxoSmithKline | NDA/BLA Number: NDA 21-254/S-007 | NDA/BLA Approval: 6/8/2006 |
| Generic Name: dalfampridine | Status: Approved |
| NDA/BLA Holder: Acorda Therapeutics | NDA/BLA Number: NDA 22-250 | NDA/BLA Approval: 1/22/2010 |
| Generic Name: testosterone | Status: Approved |
| NDA/BLA Holder: Unimed Pharmaceuticals | NDA/BLA Number: NDA 21-015/S-022 | NDA/BLA Approval: 2/28/2000 |
| Generic Name: bupropion hydrobromide | Status: Approved |
| NDA/BLA Holder: Biovail Labs | NDA/BLA Number: NDA 22-108 | NDA/BLA Approval: 4/23/2008 |
| Generic Name: darbepoetin alfa | Status: Approved |
| NDA/BLA Holder: Amgen | NDA/BLA Number: BLA 103951/5197 | NDA/BLA Approval: 9/17/2001 |
| Generic Name: rosiglitazone maleate and metformin hydrochloride | Status: Approved |
| NDA/BLA Holder: SB Pharmco | NDA/BLA Number: NDA 21-410/S-025 | NDA/BLA Approval: 10/10/2002 |
| Generic Name: rosiglitazone maleate and glimepiride | Status: Approved |
| NDA/BLA Holder: SB Pharmco | NDA/BLA Number: NDA 21-700/S-008 | NDA/BLA Approval: 11/23/2005 |
| Generic Name: moxifloxacin | Status: Approved |
| NDA/BLA Holder: Bayer | NDA/BLA Number: NDA 21-085/S-042, NDA 21-277/S-036 | NDA/BLA Approval: 12/10/1999, 11/30/2001 |
| Generic Name: rufinamide | Status: Approved |
| NDA/BLA Holder: Eisai Inc. | NDA/BLA Number: NDA 21-911 | NDA/BLA Approval: 11/14/2008 |
| Generic Name: onabotulinumtoxinA | Status: Approved |
| NDA/BLA Holder: Allergan | NDA/BLA Number: BLA 103000/5210, 5209 | NDA/BLA Approval: 12/9/1991 |
| Generic Name: buprenorphine Transdermal System | Status: Approved |
| NDA/BLA Holder: Purdue Pharma | NDA/BLA Number: NDA 21-306/S-001 | NDA/BLA Approval: 06/30/2010 |
| Generic Name: exanatide | Status: Approved |
| NDA/BLA Holder: Amylin | NDA/BLA Number: NDA 21-773/S-009, S-011, S-017, S-018, S-022, S-025, NDA 21-919 | NDA/BLA Approval: 4/28/2005, 10/30/2009 |
| Generic Name: diclofenac potassium | Status: Approved |
| NDA/BLA Holder: Kowa | NDA/BLA Number: NDA 22-165 | NDA/BLA Approval: 6/17/2009 |
| Generic Name: varenicline | Status: Approved |
| NDA/BLA Holder: Pfizer | NDA/BLA Number: NDA 21-928/S-011 | NDA/BLA Approval: 5/10/2006 |
| Generic Name: certolizumab pegol | Status: Approved |
| NDA/BLA Holder: UCB | NDA/BLA Number: BLA 125160/0 | NDA/BLA Approval: 4/22/2008 |
| Generic Name: ciprofloxacin | Status: Approved |
| NDA/BLA Holder: Bayer | NDA/BLA Number: NDA 19-537/S-070, NDA 19-847/S-044, NDA 19-857/S-051, NDA 20-780/S-028, NDA 21-473/S-025 | NDA/BLA Approval: 10/22/1987, 12/26/1990, 12/26/1990, 9/26/1997, 12/13/2002 |
| Generic Name: colchicine | Status: Approved |
| NDA/BLA Holder: Mutual Pharma | NDA/BLA Number: NDA 22-351 | NDA/BLA Approval: 7/30/2009 |
| Generic Name: colchicine | Status: Approved |
| NDA/BLA Holder: AR Holding Co, Inc. | NDA/BLA Number: NDA 22-352 | NDA/BLA Approval: 7/29/2009 |
| Generic Name: colchicine | Status: Approved |
| NDA/BLA Holder: Mutual Pharma | NDA/BLA Number: NDA 22-353 | NDA/BLA Approval: 10/16/2009 |
| Generic Name: ribavirin | Status: Approved |
| NDA/BLA Holder: Roche | NDA/BLA Number: NDA 21-511 | NDA/BLA Approval: 12/2/2002 |
| Generic Name: pancrelipase | Status: Approved |
| NDA/BLA Holder: Solvay | NDA/BLA Number: NDA 20-725 | NDA/BLA Approval: 4/30/2009 |
| Generic Name: propoxyphene tablets | Status: Approved |
| NDA/BLA Holder: Xanodyne | NDA/BLA Number: NDA 10-997/S-051, S-052; NDA 16-062/S-041, S-042; NDA 17-122/S-061, S-062 | NDA/BLA Approval: 8/16/1957, 9/9/197, 12/19/1972 |
| Generic Name: pioglitazone hydrochloride and glimepiride | Status: Approved |
| NDA/BLA Holder: Takeda | NDA/BLA Number: NDA 21-925/S-007 | NDA/BLA Approval: 7/28/2006 |
| Generic Name: mometasone furoate and formoterol fumarate | Status: Approved |
| NDA/BLA Holder: Schering | NDA/BLA Number: NDA 22-518 | NDA/BLA Approval: 06/22/2010 |
| Generic Name: abobotulinumtoxin A | Status: Approved |
| NDA/BLA Holder: Ipsen | NDA/BLA Number: BLA 125274/0, 125274/1 | NDA/BLA Approval: 4/30/2009 |
| Generic Name: zolpidem tartrate | Status: Approved |
| NDA/BLA Holder: Orexo AB | NDA/BLA Number: NDA 21-997 | NDA/BLA Approval: 3/13/2009 |
| Generic Name: prasugrel | Status: Approved |
| NDA/BLA Holder: Eli Lilly and Company | NDA/BLA Number: NDA 22-307 | NDA/BLA Approval: 7/10/2009 |
| Generic Name: morphine sulfate and naltrexone hydrochloride | Status: Approved |
| NDA/BLA Holder: King Pharmaceuticals | NDA/BLA Number: NDA 22-321 | NDA/BLA Approval: 8/13/2009 |
| Generic Name: etanercept | Status: Approved |
| NDA/BLA Holder: Immunex / Amgen | NDA/BLA Number: BLA 103795/5359 | NDA/BLA Approval: 11/2/1998 |
| Generic Name: alvimopan | Status: Approved |
| NDA/BLA Holder: Adolor | NDA/BLA Number: NDA 21-775 | NDA/BLA Approval: 5/20/2008 |
| Generic Name: epoetin alfa | Status: Approved |
| NDA/BLA Holder: Amgen | NDA/BLA Number: BLA 103234/5199 | NDA/BLA Approval: 6/1/1989 |
| Generic Name: abacavir sulfate and lamivudine | Status: Approved |
| NDA/BLA Holder: GlaxoSmithKline | NDA/BLA Number: NDA 21-652/S-008 | NDA/BLA Approval: 8/2/2004 |
| Generic Name: interferon beta-1 b | Status: Approved |
| NDA/BLA Holder: Novartis | NDA/BLA Number: BLA 125290/0 | NDA/BLA Approval: 8/14/2009 |
| Generic Name: gemifloxacin | Status: Approved |
| NDA/BLA Holder: Oscient | NDA/BLA Number: NDA 21-158/S-014 | NDA/BLA Approval: 4/4/2003 |
| Generic Name: Teriparatide [rDNA origin] | Status: Approved |
| NDA/BLA Holder: Eli Lilly and Company | NDA/BLA Number: NDA 21-318 | NDA/BLA Approval: 11/26/2002 |
| Generic Name: bisacodyl, polyethylene glycol 3500, KCl, NaHCO3, NaCl | Status: Approved |
| NDA/BLA Holder: Braintree | NDA/BLA Number: NDA 21-551/S-013 | NDA/BLA Approval: 05/10/2004 |
| Generic Name: interferon alfacon-1 | Status: Approved |
| NDA/BLA Holder: Intermune | NDA/BLA Number: BLA 103663/5074 | NDA/BLA Approval: 10/6/1997 |
| Generic Name: interferon alfa-2a | Status: Approved |
| NDA/BLA Holder: Schering | NDA/BLA Number: BLA 103132/5108 | NDA/BLA Approval: 6/1/1986 |
| Generic Name: ecallentide | Status: Approved |
| NDA/BLA Holder: Dyax Corporation | NDA/BLA Number: BLA 125277 | NDA/BLA Approval: 11/27/2009 |
| Generic Name: lopinavir and ritonavir | Status: Approved |
| NDA/BLA Holder: Abbott | NDA/BLA Number: NDA 21-251/S-023, NDA 21-906/S-014 | NDA/BLA Approval: 11/15/2000, 10/28/2005 |
| Generic Name: levetiracetam | Status: Approved |
| NDA/BLA Holder: UCB | NDA/BLA Number: NDA 21-035/S-078, S-080, NDA 21-505/S-021, S-024 | NDA/BLA Approval: 11/30/1999, 7/15/2003 |
| Generic Name: lamotrigine | Status: Approved |
| NDA/BLA Holder: GlaxoSmithKline | NDA/BLA Number: NDA 22-115/S-001, S-005 | NDA/BLA Approval: 5/29/2009 |
| Generic Name: lamotrigine | Status: Approved |
| NDA/BLA Holder: GlaxoSmithKline | NDA/BLA Number: NDA 20-241/S-037, S-038, NDA 20-764/S-030, 031 | NDA/BLA Approval: 12/27/1994, 8/24/1998 |
| Generic Name: lamotrigine | Status: Approved |
| NDA/BLA Holder: GSK | NDA/BLA Number: NDA 22-509/S-001 | NDA/BLA Approval: 5/29/2009 |
| Generic Name: mefloquine hydrochloride | Status: Discontinued |
| NDA/BLA Holder: Roche | NDA/BLA Number: NDA 19-591/S-026, 19-591/S-028 | NDA/BLA Approval: 5/2/1989 |
| Generic Name: ambrisentan | Status: Approved |
| NDA/BLA Holder: Gilead Sciences, Inc. | NDA/BLA Number: NDA 22-081 | NDA/BLA Approval: 6/15/2007 |
| Generic Name: levofloxacin | Status: Approved |
| NDA/BLA Holder: Ortho McNeil Janssen | NDA/BLA Number: NDA 20-634/ S-053, NDA 20-635/ S-058, NDA 21-721/ S-021 | NDA/BLA Approval: 12/20/1996, 12/20/1996, 10/21/2004 |
| Generic Name: alglucosidase alfa | Status: Approved |
| NDA/BLA Holder: Genzyme | NDA/BLA Number: BLA 125291 | NDA/BLA Approval: 05/24/2010 |
| Generic Name: pregabalin | Status: Approved |
| NDA/BLA Holder: CP Pharms | NDA/BLA Number: NDA 21-446/S-013, S-014 | NDA/BLA Approval: 12/30/2004 |
| Generic Name: metoclopramide hydrochloride | Status: Approved |
| NDA/BLA Holder: Silarx | NDA/BLA Number: ANDA 73-680/S-018 | NDA/BLA Approval: 10/27/1992 |
| Generic Name: metoclopramide hydrochloride | Status: Approved |
| NDA/BLA Holder: Morton Grove | NDA/BLA Number: ANDA 74-703/S-007 | NDA/BLA Approval: 10/31/1997 |
| Generic Name: metoclopramide hydrochloride | Status: Approved |
| NDA/BLA Holder: Pharmaceutical Associates | NDA/BLA Number: ANDA 72-744/S-011 | NDA/BLA Approval: 5/28/1991 |
| Generic Name: metoclopramide hydrochloride | Status: Approved |
| NDA/BLA Holder: ANI Pharmaceuticals | NDA/BLA Number: ANDA 71-402/S-008 | NDA/BLA Approval: 6/25/1993 |
| Generic Name: metoclopramide hydrochloride | Status: Approved |
| NDA/BLA Holder: Salix | NDA/BLA Number: NDA 22-246 | NDA/BLA Approval: 9/4/2009 |
| Generic Name: morphine sulfate | Status: Approved |
| NDA/BLA Holder: Roxane | NDA/BLA Number: NDA 22-195/S-002 | NDA/BLA Approval: 3/17/2008 |
| Generic Name: dronedarone | Status: Approved |
| NDA/BLA Holder: sanofi-aventis | NDA/BLA Number: NDA 22-425 | NDA/BLA Approval: 7/1/2009 |
| Generic Name: rimabotulinumtoxinB | Status: Approved |
| NDA/BLA Holder: Elan | NDA/BLA Number: BLA 103846/5120 | NDA/BLA Approval: 12/8/2000 |
| Generic Name: primidone | Status: Approved |
| NDA/BLA Holder: Valeant Pharmaceuticals | NDA/BLA Number: NDA 9170/S-035 | NDA/BLA Approval: 03/8/1954 |
| Generic Name: norfloxacin | Status: Approved |
| NDA/BLA Holder: Merck | NDA/BLA Number: NDA 19-384/S-054 | NDA/BLA Approval: 10/31/1986 |
| Generic Name: romiplostim | Status: Approved |
| NDA/BLA Holder: Amgen | NDA/BLA Number: BLA 125268 | NDA/BLA Approval: 8/22/2008 |
| Generic Name: trazadone hydrochloride | Status: Approved |
| NDA/BLA Holder: Labopharm | NDA/BLA Number: NDA 22-411 | NDA/BLA Approval: 2/2/2010 |
| Generic Name: fentanyl buccal soluble film | Status: Approved |
| NDA/BLA Holder: BioDelivery Science International Inc. | NDA/BLA Number: NDA 22-226 | NDA/BLA Approval: 7/16/2009 |
| Generic Name: sodium phosphate, dibasic anhydrous and sodium phosphate, monobasic, monohydrate | Status: Approved |
| NDA/BLA Holder: Salix Pharmaceuticals | NDA/BLA Number: NDA 21-892/S-004 | NDA/BLA Approval: 3/16/2006 |
| Generic Name: Ethotoin | Status: Approved |
| NDA/BLA Holder: Lundbeck Inc. | NDA/BLA Number: NDA 10-841 | NDA/BLA Approval: 04/22/1957 |
| Generic Name: peginterferon alfa-2a | Status: Approved |
| NDA/BLA Holder: Hoffman-La Roche | NDA/BLA Number: BLA 103964 | NDA/BLA Approval: 10/16/2002 |
| Generic Name: peginterferon alfa-2b | Status: Approved |
| NDA/BLA Holder: Schering | NDA/BLA Number: BLA 103949/5171, 5174 | NDA/BLA Approval: 1/19/2001 |
| Generic Name: peginterferon alfa-2b, | Status: Approved |
| NDA/BLA Holder: Schering | NDA/BLA Number: BLA 125196/0 | NDA/BLA Approval: 6/13/2008 |
| Generic Name: diclofenac sodium | Status: Approved |
| NDA/BLA Holder: Nuvo Research | NDA/BLA Number: NDA 20-947 | NDA/BLA Approval: 11/4/2009 |
| Generic Name: denosumab | Status: Approved |
| NDA/BLA Holder: Amgen | NDA/BLA Number: BLA 125320 | NDA/BLA Approval: 06/01/2010 |
| Generic Name: eltrombopag | Status: Approved |
| NDA/BLA Holder: GlaxoSmithKline | NDA/BLA Number: NDA 22-291 | NDA/BLA Approval: 11/20/2008 |
| Generic Name: ciprofloxacin | Status: Approved |
| NDA/BLA Holder: Depomed Inc | NDA/BLA Number: NDA 21-744/S-012 | NDA/BLA Approval: 5/19/2005 |
| Generic Name: quinine sulfate | Status: Approved |
| NDA/BLA Holder: AR Holding Co Inc. | NDA/BLA Number: NDA 21-799 | NDA/BLA Approval: 08/12/2005 |
| Generic Name: ribivarin | Status: Approved |
| NDA/BLA Holder: Schering Plough | NDA/BLA Number: NDA 20-903/S-042, S-043, S-044, S-045, NDA 21-546/S-001 | NDA/BLA Approval: 6/3/1998, 7/29/2003 |
| Generic Name: metoclopramide hydrochloride | Status: Approved |
| NDA/BLA Holder: Alaven Pharmaceuticals | NDA/BLA Number: NDA 17-854/S-052 | NDA/BLA Approval: 12/30/1980 |
| Generic Name: metoclopramide hydrochloride | Status: Approved |
| NDA/BLA Holder: Alvena Pharmaceutical | NDA/BLA Number: NDA 21-793/S-005 | NDA/BLA Approval: 6/10/2005 |
| Generic Name: infliximab | Status: Approved |
| NDA/BLA Holder: Centocor | NDA/BLA Number: BLA 103772/5258 | NDA/BLA Approval: 8/24/1998 |
| Generic Name: lenalidomide | Status: Approved |
| NDA/BLA Holder: Celgene | NDA/BLA Number: (NDA) 021880 | NDA/BLA Approval: 12/27/2005 |
| Generic Name: ramelteon | Status: Approved |
| NDA/BLA Holder: Takeda | NDA/BLA Number: NDA 21-782/S-008, S-009, S-010 | NDA/BLA Approval: 7/22/2005 |
| Generic Name: vigabatrin | Status: Approved |
| NDA/BLA Holder: Lundbeck | NDA/BLA Number: NDA 22-006, NDA 20-427 | NDA/BLA Approval: 8/21/2009 |
| Generic Name: tolvaptan | Status: Approved |
| NDA/BLA Holder: Otsuka America Pharmaceutical | NDA/BLA Number: NDA 22-275 | NDA/BLA Approval: 5/19/2009 |
| Generic Name: milnacipran hydrochloride | Status: Approved |
| NDA/BLA Holder: Cypress Bioscience | NDA/BLA Number: NDA 22-256 | NDA/BLA Approval: 1/14/2009 |
| Generic Name: quetiapine | Status: Approved |
| NDA/BLA Holder: AstraZeneca | NDA/BLA Number: NDA 20-639/S-045, S-046 | NDA/BLA Approval: 9/26/1997 |
| Generic Name: quetiapine | Status: Approved |
| NDA/BLA Holder: AstraZeneca | NDA/BLA Number: NDA 22-047/S-011, S-016, S-017, S-019, S-022 | NDA/BLA Approval: 5/17/2007 |
| Generic Name: golimumab | Status: Approved |
| NDA/BLA Holder: Centocor Ortho Biotech | NDA/BLA Number: BLA 125289 | NDA/BLA Approval: 4/24/2009 |
| Generic Name: eculizumab | Status: Approved |
| NDA/BLA Holder: Alexion Pharmaceuticals, Inc. | NDA/BLA Number: BLA 125166/44 | NDA/BLA Approval: 3/16/2007 |
| Generic Name: ustekinumab | Status: Approved |
| NDA/BLA Holder: Centocor Ortho Biotech | NDA/BLA Number: BLA 125261 | NDA/BLA Approval: 9/25/2009 |
| Generic Name: sacrosidase | Status: Approved |
| NDA/BLA Holder: QOL Medical | NDA/BLA Number: NDA 20-772/S-005 | NDA/BLA Approval: 4/9/1998 |
| Generic Name: budesonide and formoterol | Status: Approved |
| NDA/BLA Holder: AstraZeneca | NDA/BLA Number: NDA 21-929/S-012 | NDA/BLA Approval: 7/21/2006 |
| Generic Name: olanzapine and fluoxetine | Status: Approved |
| NDA/BLA Holder: Eli Lilly | NDA/BLA Number: NDA 21-520/S-012 | NDA/BLA Approval: 12/24/2003 |
| Generic Name: Tapentadol Tablets | Status: Approved Not Marketed |
| NDA/BLA Holder: Ortho McNeil Janssen | NDA/BLA Number: NDA 22-304 | NDA/BLA Approval: 11/20/2008 |
| Generic Name: testosterone | Status: Approved |
| NDA/BLA Holder: Auxilium | NDA/BLA Number: NDA 21-454/S-008 | NDA/BLA Approval: 10/31/2002 |
| Generic Name: topiramate | Status: Approved |
| NDA/BLA Holder: Ortho McNeil Janssen | NDA/BLA Number: NDA 20-505/S-038, S-039, NDA 20-844/S-032, S-034 | NDA/BLA Approval: 12/24/1996, 10/26/1998 |
| Generic Name: bosentan | Status: Approved |
| NDA/BLA Holder: Actelion Pharmaceuticals US, Inc. | NDA/BLA Number: NDA 21-290 | NDA/BLA Approval: 11/20/2001 |
| Generic Name: clorazepate dipotassium | Status: Approved |
| NDA/BLA Holder: Lundbeck Inc. | NDA/BLA Number: NDA 17-105 | NDA/BLA Approval: 06/23/1972 |
| Generic Name: sumatriptan succinate and naproxen sodium | Status: Approved |
| NDA/BLA Holder: GlaxoSmithKline | NDA/BLA Number: NDA 21-926 | NDA/BLA Approval: 4/15/2008 |
| Generic Name: fenofibric acid | Status: Approved |
| NDA/BLA Holder: Abbott | NDA/BLA Number: NDA 22-224 | NDA/BLA Approval: 12/15/2008 |
| Generic Name: abacavir sulfate, lamivudine, and zidovudine | Status: Approved |
| NDA/BLA Holder: GlaxoSmithKline | NDA/BLA Number: NDA 21-205/S-021 | NDA/BLA Approval: 11/14/2000 |
| Generic Name: telbivudine | Status: Approved |
| NDA/BLA Holder: Novartis | NDA/BLA Number: NDA 22-154 | NDA/BLA Approval: 4/28/2009 |
| Generic Name: telbivudine | Status: Approved |
| NDA/BLA Holder: Novartis | NDA/BLA Number: NDA 22-011/S-001 | NDA/BLA Approval: 11/25/2006 |
| Generic Name: venlafaxine hydrochloride | Status: Approved |
| NDA/BLA Holder: Osmotica Pharm | NDA/BLA Number: NDA 22-104 | NDA/BLA Approval: 5/20/2008 |
| Generic Name: telavancin | Status: Approved |
| NDA/BLA Holder: Theravance | NDA/BLA Number: NDA 22-110 | NDA/BLA Approval: 9/11/2009 |
| Generic Name: liraglutide | Status: Approved |
| NDA/BLA Holder: Novo Nordisk | NDA/BLA Number: NDA 22-341 | NDA/BLA Approval: 1/25/2010 |
| Generic Name: didanosine | Status: Approved |
| NDA/BLA Holder: BMS | NDA/BLA Number: NDA 20-156/S-046, NDA 21-183/S-023 | NDA/BLA Approval: 10/9/1991, 10/23/2000 |
| Generic Name: lacosamide | Status: Approved |
| NDA/BLA Holder: Schwarz Biosciences | NDA/BLA Number: NDA 22-253, 22-254 | NDA/BLA Approval: 11/28/2008 |
| Generic Name: nevirapine | Status: Approved |
| NDA/BLA Holder: Boehringer Ingelheim | NDA/BLA Number: NDA 20-636/S-027, NDA 20-933/S-017 | NDA/BLA Approval: 6/21/1996, 9/11/1998 |
| Generic Name: sodium phosphate, dibasic anhydrous and sodium phosphate, monobasic, monohydrate | Status: Approved |
| NDA/BLA Holder: Salix Pharmaceuticals | NDA/BLA Number: NDA 21-097/S-014 | NDA/BLA Approval: 9/21/2000 |
| Generic Name: pazopanib | Status: Approved |
| NDA/BLA Holder: GSK | NDA/BLA Number: NDA 22-465 | NDA/BLA Approval: 10/19/2009 |
| Generic Name: tetrabenazine | Status: Approved |
| NDA/BLA Holder: Biovail Americas | NDA/BLA Number: NDA 21-894 | NDA/BLA Approval: 8/15/2008 |
| Generic Name: collagenase clostridium histolyticum | Status: Approved |
| NDA/BLA Holder: Auxilium | NDA/BLA Number: BLA 125338 | NDA/BLA Approval: 2/2/2010 |
| Generic Name: omalizumab | Status: Approved |
| NDA/BLA Holder: Genentech | NDA/BLA Number: BLA 103976/5154 | NDA/BLA Approval: 6/20/2003 |
| Generic Name: pancrelipase | Status: Approved |
| NDA/BLA Holder: Eurand | NDA/BLA Number: NDA 22-210 | NDA/BLA Approval: 8/27/2009 |
| Generic Name: abacavir sulfate | Status: Approved |
| NDA/BLA Holder: GlaxoSmithKline | NDA/BLA Number: NDA 20-977/S-017, NDA 20-978/S-020 | NDA/BLA Approval: 12/17/1998, 12/17/1998 |
| Generic Name: zolpidem tartrate | Status: Approved |
| NDA/BLA Holder: Novadel | NDA/BLA Number: NDA 22-196 | NDA/BLA Approval: 12/19/2008 |
| Generic Name: zonisamide | Status: Approved |
| NDA/BLA Holder: Dainippon | NDA/BLA Number: NDA 20-789/S-022, S-025 | NDA/BLA Approval: 3/27/2000 |
| Generic Name: olanzapine | Status: Approved |
| NDA/BLA Holder: Eli Lilly | NDA/BLA Number: NDA 22-173 | NDA/BLA Approval: 12/11/2009 |
| Generic Name: olanzapine | Status: Approved |
| NDA/BLA Holder: Eli Lilly | NDA/BLA Number: NDA 20-592/S-039, NDA 21-086/S-021 | NDA/BLA Approval: 9/30/1996, 4/6/2000 |
| Generic Name: Small pox (Vaccinia) Vaccine, Live | Status: Approved |
| NDA/BLA Holder: Acambis | NDA/BLA Number: BLA 125158 | NDA/BLA Approval: 8/31/2007 |
| Generic Name: isotretinoin | Status: Approved |
| NDA/BLA Holder: Hoffman LaRoche | NDA/BLA Number: NDA 18-662 | NDA/BLA Approval: 5/7/1982 |
| Generic Name: fentanyl citrate | Status: Approved |
| NDA/BLA Holder: Cephalon | NDA/BLA Number: NDA 20-747 | NDA/BLA Approval: 11/4/1998 |
| Generic Name: isotretinoin | Status: Approved |
| NDA/BLA Holder: Hoffman LaRoche | NDA/BLA Number: ANDA 75-945 | NDA/BLA Approval: Nov-02 |
| Generic Name: isotretinoin | Status: Approved |
| NDA/BLA Holder: Barr Pharmaceuticals, Inc. Teva Pharmaceuticals In | NDA/BLA Number: ANDA 76-135, ANDA 76-356 | NDA/BLA Approval: 4/11/2003 |
| Generic Name: clozapine | Status: Approved |
| NDA/BLA Holder: Novartis Pharmaceuticals Corp. | NDA/BLA Number: NDA 19-758 | NDA/BLA Approval: 9/26/1989 |
| Generic Name: clozapine | Status: Approved |
| NDA/BLA Holder: Ivax Pharms | NDA/BLA Number: ANDA 74-949 | NDA/BLA Approval: 11/26/1997 |
| Generic Name: clozapine | Status: Approved |
| NDA/BLA Holder: Mylan Laboratories | NDA/BLA Number: ANDA 75-417 | NDA/BLA Approval: 5/27/1999 |
| Generic Name: clozapine | Status: Approved |
| NDA/BLA Holder: Caraco Pharmaceutical Laboratories | NDA/BLA Number: ANDA 75-713 | NDA/BLA Approval: 11/15/2002 |
| Generic Name: clozapine | Status: Discont'd |
| NDA/BLA Holder: Par Pharm | NDA/BLA Number: ANDA 75-162 | NDA/BLA Approval: 4/26/2005 |
| Generic Name: clozapine | Status: Approved |
| NDA/BLA Holder: Goldline | NDA/BLA Number: ANDA 76-809 | NDA/BLA Approval: 12/16/2005 |
| Generic Name: clozapine | Status: Approved |
| NDA/BLA Holder: Azur Pharma International | NDA/BLA Number: NDA 21-590 | NDA/BLA Approval: 2/9/2004 |
| Generic Name: fentanyl PCA | Status: Approved - Not Available in U.S. Market |
| NDA/BLA Holder: Alza | NDA/BLA Number: NDA 21-338 | NDA/BLA Approval: 5/22/2006 |
| Generic Name: alosetron | Status: Approved |
| NDA/BLA Holder: Prometheus Labs | NDA/BLA Number: NDA 21-107 | NDA/BLA Approval: 2/9/2000 |
| Generic Name: mifepristone | Status: Approved |
| NDA/BLA Holder: Danco Laboratories | NDA/BLA Number: NDA 20-687 | NDA/BLA Approval: 9/28/2000 |
| Generic Name: abarelix | Status: Discontinued |
| NDA/BLA Holder: Speciality European | NDA/BLA Number: NDA 21-320 | NDA/BLA Approval: 11/25/2003 |
| Generic Name: lenalidomide | Status: Approved |
| NDA/BLA Holder: Celgene | NDA/BLA Number: NDA 21-880 | NDA/BLA Approval: 12/27/2005 |
| Generic Name: isotretinoin | Status: Approved |
| NDA/BLA Holder: Hoffman LaRoche | NDA/BLA Number: ANDA 76-041, ANDA 76-503 | NDA/BLA Approval: 12/24/2002, 6/20/2003 |
| Generic Name: thalidomide | Status: Approved |
| NDA/BLA Holder: Celgene | NDA/BLA Number: NDA 20-785 | NDA/BLA Approval: 7/16/1998 |
| Generic Name: thalidomide | Status: Approved |
| NDA/BLA Holder: Celgene | NDA/BLA Number: NDA 21-430 | NDA/BLA Approval: 7/16/1998 |
| Generic Name: dofetilide | Status: Approved |
| NDA/BLA Holder: Pfizer | NDA/BLA Number: NDA 20-931 | NDA/BLA Approval: 0/01/1999 |
| Generic Name: natalizumab | Status: Approved |
| NDA/BLA Holder: Biogen Idec | NDA/BLA Number: BLA 125104 | NDA/BLA Approval: 11/23/2004 |
| Generic Name: sodium oxybate | Status: Approved |
| NDA/BLA Holder: Jazz Pharmaceuticals | NDA/BLA Number: NDA 21-196 | NDA/BLA Approval: 7/17/2002 |